Earnings call transcript: Procter & Gamble tops Q1 2027 estimates as shares jump

Procter & Gamble reported Q1 2027 earnings of $2.00 per share, beating estimates of $1.89, on revenue of $23.28B, exceeding forecasts of $22.82B. Organic sales grew 4.0%, with all 10 product categories showing growth. Shares rose 5.84% in premarket trading. The company maintained its full-year guidance but raised its cost headwind outlook to $1.4B after tax.

Original reporting
Published Oct 22, 2026, 1:48 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 22, 2026, 2:30 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$PG
Bullish
high confidence
Mentioned
$PG
Relevance
9/10
AlphAI data visualization · based on uk.investing.com
Decision brief

The 30-second read

$PGBullishHigh
01

Why it matters

The beat sparked a 5.8% pre‑market rally, indicating strong investor demand for the stock despite rising input costs.

02

Market read

First‑report earnings for a large‑cap consumer staple; immediate price impact and sector‑wide implications.

03

What to watch

The unchanged FY guidance despite cost pressure may signal future margin compression.

Relevance 9/10Novelty 9/10Timing: pre‑market today

Background

Procter & Gamble released its fiscal Q1 2027 earnings, beating both earnings and revenue estimates.

Company-level read

Ticker impact

$PGBullishHigh confidence
Context

PG reported Q1 FY2027 core EPS $2.00 vs $1.89 estimate and revenue $23.28B vs $22.82B, sending the stock up 5.84% pre‑market.

Expected impact

upward bias as market prices in the earnings beat and robust sales growth

Evidence & confidence

The beat is material for a large‑cap consumer staple; the pre‑market rally confirms immediate buying pressure, while raised cost outlook suggests caution on the upside.

Market effects

Consumer staples may see broader optimism as a bellwether beats, but cost‑inflation concerns could affect peers.

U.S. market gains from the beat; European and Asian markets may react to cost‑headwind commentary.

Limited to consumer‑goods sector, but the move influences risk‑on sentiment in equities.

Counterpoint

Higher raw‑material and freight costs could erode margins, making the rally potentially short‑lived.

Key entities

  • Andre Schulten

    Chief Financial Officer who commented on growth and cost pressures.

Related articles

$PGMed

P&G Plans To Cut Up To 30% Product Supply Jobs By 2030; Confirms FY27 Outlook

Procter & Gamble (P&G) plans to cut 20-30% of product supply jobs by 2030, aiming for $10B in productivity savings. The company maintained its FY27 outlook, projecting 2-4% net sales growth and 1-3% organic sales growth. P&G also expects $1.8B in annual productivity savings and $30B in growth opportunities. Shares gained 0.30% to $168.35 in overnight trading.

$PGMedAI 9/10

The Procter & Gamble Company closed an underwritten public offering of €750,000,000 aggregate principal amount of 3.750% Notes due November 3, 2030…

PROCTER & GAMBLE Co (PG) filed an SEC Form 8-K — Other Events. Item 8.01 Other Events. On November 3, 2026, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of €750,000,000 aggregate principal amount of 3.750% Notes due November 3, 2030, €1,000,000,000 aggregate principal amount of 4.100% Notes due November